From Medscape Oncology

Coverage from the

Transplantation and Cellular Therapy (TCT) 2019:

Joint Meeting of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)

February 20 - 24, 2019; Houston, Texas

February 20 - 24, 2019 Houston, Texas
  • ASBMT 2019 Ixazomib Shows Promise as Option for Chronic GVHD Patients with advanced chronic graft versus host disease who have failed multiple therapies may respond to ixazomib, a drug approved for second-line multiple myeloma treatment, say US scientists.
  • ASBMT 2019 Simple Changes Boost Sleep Quality in Hospital Rescheduling trash pulls from rooms, fixing noisy doors, and stopping corridor conversations could all improve sleep quality for hospital patients, say US researchers.
  • ASBMT 2019 Cord Blood Instead of Bone Marrow for HSCT for Blood Cancers Clinicians should get over their preconceptions about sourcing stem cells from cord blood for transplants in hematologic malignancies, as it can achieve good short- and long-term outcomes, says an expert in the field.

Conference News

Popular Blood and Marrow Transplantation News From 2018

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage